Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Enanta Pharmaceutica
(NQ:
ENTA
)
8.570
-0.030 (-0.35%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
531,819
Open
8.610
Bid (Size)
8.300 (1)
Ask (Size)
8.940 (1)
Prev. Close
8.600
Today's Range
8.350 - 8.710
52wk Range
8.000 - 17.80
Shares Outstanding
21,055,392
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
4 Analysts Assess Enanta Pharma: What You Need To Know
November 26, 2024
Via
Benzinga
Enanta Pharma Earnings Analysis: Q4 Recap
November 25, 2024
Via
Benzinga
Performance
YTD
-14.98%
-14.98%
1 Month
-22.86%
-22.86%
3 Month
-32.09%
-32.09%
6 Month
-30.78%
-30.78%
1 Year
-14.30%
-14.30%
More News
Read More
Enanta Pharma Q4 Earnings Assessment
November 25, 2024
Via
Benzinga
Insights into Enanta Pharma Q4 Earnings
November 25, 2024
Via
Benzinga
Enanta Pharma: Q4 Earnings Insights
November 25, 2024
Via
Benzinga
Earnings Breakdown: Enanta Pharma Q4
November 25, 2024
Via
Benzinga
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024
November 25, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharma's Earnings Outlook
November 22, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts
October 09, 2024
Via
Benzinga
Recap: Enanta Pharma Q1 Earnings
February 07, 2024
Via
Benzinga
Earnings Scheduled For November 25, 2024
November 25, 2024
Via
Benzinga
Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study
September 26, 2024
Via
Benzinga
Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)
September 26, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate in Investor Conferences in September
September 03, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
ENTA Stock Earnings: Enanta Pharma Beats EPS, Beats Revenue for Q3 2024
August 05, 2024
Via
InvestorPlace
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter
August 05, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
May 29, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
May 07, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
ENTA Stock Earnings: Enanta Pharma Misses EPS, Beats Revenue for Q2 2024
May 06, 2024
Via
InvestorPlace
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
May 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 30, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
April 30, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
April 29, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
April 17, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
March 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.